Issued Patents All Time
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12084498 | Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma | HÉLÈNE SICARD, RENAUD BUFFET | 2024-09-10 |
| 11999784 | Treatment of peripheral T cell lymphoma | HÉLÈNE SICARD, RENAUD BUFFET, Mathieu Blery | 2024-06-04 |
| 11078275 | Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma | HÉLÈNE SICARD, RENAUD BUFFET | 2021-08-03 |
| 10736963 | Methods for detecting tissue infiltrating NK cells | Nadia Anceriz, Arnaud Dujardin, Carine Paturel | 2020-08-11 |
| 10577416 | Mica binding agents | Mathieu Blery, Laurent Gauthier, Ivan Perrot | 2020-03-03 |
| 10494433 | Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma | Pascale Andre, Mathieu Blery, Ashok K. Gupta, Luisa Salter-Cid, Michael Robbins | 2019-12-03 |
| 10344087 | Treatment of peripheral T cell lymphoma | HÉLÈNE SICARD, RENAUD BUFFET, Mathieu Blery | 2019-07-09 |
| 10174112 | Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma | HÉLÈNE SICARD, RENAUD BUFFET | 2019-01-08 |
| 9944712 | TLR3 binding agents | Laurent Gauthier, Yannis Morel, Carine Paturel, Ivan Perrot | 2018-04-17 |